[1] Avery P, Morton S, Tucker H, et al.Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage[J].Emergency Medicine Journal, 2020, 37(6):370-378.
[2] Ali, Maleki, Fatemeh, et al.The Statue of Cytokines Therapy in Blood Transfusion Running Cytokine and Blood Transfusion[J].Cell and Tissue Biology, 2019, 13(6):407-417.
[3] Koda Y, Nishida H, Kagan V, et al.Clinical Outcomes of Left Ventricular Assist Device Implantation for Patients Refusing Blood Transfusion[J].The Journal of Heart and Lung Transplantation, 2020, 39(4):S427.
[4] 张红, 谢跃文, 李茂, 等.去白细胞成分输血对肿瘤患者的价值及输血不良反应、术后感染率的改善分析[J].解放军预防医学杂志, 2019, 37(2):124-125.
[5] 贺英, 李金翌, 邹昆, 等.某医院2013年~2019年储存悬浮少白细胞红细胞临床使用及不良反应情况调查[J].湖南师范大学学报(医学版), 2020, 17(5):47-50.
[6] Seghatchian J.Reflections on current status of blood transfusion transplant viral safety in UK/Europe and on novel strategies for enhancing donors/recipients healthcare in promising era of advanced cell therapy/regenerative medicine[J].Transfusion and Apheresis Science, 2019, 58(4):532-537.
[7] 钟胜英. 血浆置换与去白细胞红细胞悬液输血治疗混合抗体型自身免疫性溶血性贫血的效果[J].中国民康医学, 2020, 32(3):6-8.
[8] 莫水群, 曾月婷, 蔡肇丽, 等.常规输血与少白细胞技术输血对输血不良反应的降低作用[J].中国卫生标准管理, 2020, 11(2):124-126.
[9] 缪小花, 陈娟, 吴春梅.少白细胞输血技术在降低输血不良反应中的效果[J].临床合理用药杂志, 2020, 13(8):147-149.
[10] Delaney M, Barber J R, Andrews J, et al.Multinational Analysis of Transfusion Reactions in Children Transfused with Pathogen Inactivated Platelets[J].Transfusion, 2021, 61(3):8-9.
[11] 永台. 少白细胞输血与常规输血在降低输血不良反应方面的差异比较[J].世界最新医学信息文摘(电子版), 2019, 019(087):126-127.
[12] Vo P, Purev E, West K A, et al.A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo immunized patients[J].British journal of haematology, 2020, 189(3): 551-558. |
2023, Vol. 43 
